Baltimore still won’t say how it will spend $45 million opioids settlement

Baltimore has received the $45 million that pharmaceutical company Allergan agreed to pay as part of the city’s lawsuit over the opioid epidemic, but officials have not yet said how they plan to use the bulk of the money, or who will be making those decisions. The Department of Finance is processing the settlement, the mayor’s spokesperson Bryan Doherty said in an email. More information will be announced soon, he said.